Free Trial
OTCMKTS:HBPCF

Helix BioPharma (HBPCF) Stock Price, News & Analysis

Helix BioPharma logo
$0.59 0.00 (0.00%)
As of 05/1/2025

About Helix BioPharma Stock (OTCMKTS:HBPCF)

Key Stats

Today's Range
$0.59
$0.59
50-Day Range
$0.45
$0.59
52-Week Range
$0.45
$0.92
Volume
N/A
Average Volume
1,071 shs
Market Capitalization
$31.28 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Helix BioPharma Corp. operates as an immune-oncology company in Canada. It is developing L-DOS47 for the treatment of non-small cell lung cancer; and V-DOS47 that targets the vascular epithelial growth factor receptor 2. Helix BioPharma Corp. has collaboration agreements with Moffitt Cancer Center to investigate the pharmacodynamics of L-DOS47 and determine the benefits of combining L-DOS47 with immune checkpoint inhibitors; and with University Hospital Tuebingen to assess the therapeutic response of L-DOS47 in cancer models expressing CEACAM6, with advanced preclinical metabolic imaging. The company is headquartered in Toronto, Canada.

Receive HBPCF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Helix BioPharma and its competitors with MarketBeat's FREE daily newsletter.

HBPCF Stock News Headlines

Trump’s Bitcoin Reserve is No Accident…
Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new blockchain development…
See More Headlines

HBPCF Stock Analysis - Frequently Asked Questions

Helix BioPharma's stock was trading at $0.4549 at the start of the year. Since then, HBPCF shares have increased by 29.7% and is now trading at $0.59.
View the best growth stocks for 2025 here
.

Helix BioPharma Corp. (OTCMKTS:HBPCF) issued its quarterly earnings data on Friday, March, 14th. The company reported ($0.02) EPS for the quarter.

Shares of HBPCF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
3/14/2025
Today
5/02/2025
Next Earnings (Estimated)
5/12/2025
Fiscal Year End
7/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:HBPCF
CIK
N/A
Employees
9
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-6,820,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
48,992,000
Market Cap
$31.28 million
Optionable
Not Optionable
Beta
0.01

Social Links

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (OTCMKTS:HBPCF) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners